Key facts
- This page summarizes Anthony N. Amato's Form 3 filing for BioSig Technologies, Inc. (BSGM).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jul 2024, 16:00.
Anthony N. Amato - 30 Apr 2024 Form 3 Insider Report for BioSig Technologies, Inc. (BSGM)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- BSGM
- Reported as of
- 30 Apr 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 05 Jul 2024, 16:00:16 UTC
- Next SEC filing
- 13 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Anthony Amato
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Anthony N. Amato filed Form 3 for BioSig Technologies, Inc. (BSGM) on 05 Jul 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSGM
holding
Common Stock, $0.001 par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500,000
- Date
- 30 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
BSGM
holding
Common Stock, $0.001 par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,000
- Date
- 30 Apr 2024
- Ownership
- Direct
- Footnotes
- F2
BSGM
holding
Common Stock, $0.001 par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,250
- Date
- 30 Apr 2024
- Ownership
- Direct
- Footnotes
- F3
BSGM
holding
Common Stock, $0.001 par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,952
- Date
- 30 Apr 2024
- Ownership
- Direct
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The shares of restricted stock were granted for services and were fully vested as of March 1, 2024, the date of the grant, based on a closing price of $0.705 per share.
Footnote F2
The shares of restricted stock were granted for services and were fully vested as of June 7, 2024, the date of the grant, based on a closing price of $1.865 per share.
Footnote F3
Consists of (i) 2,500 shares of restricted stock granted for services on January 5, 2021 with a cost basis of $39.90 that vested in equal quarterly installments over one year, and (ii) 3,750 shares of restricted stock units granted for services on June 26, 2023 with an average cost basis of $5.05 that vested in two equal quarterly installments.
Footnote F4
The shares of common stock were purchased in a private placement on March 12, 2019, based on a price of $40.00 per share.
SEC remarks
Mr. Amato was appointed as chief executive officer of BioSig Technologies, Inc. on April 30, 2024.